Phenprocoumon: Clinical Trials

5 trials of Phenprocoumon, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Terminated 1, Unknown 1

Follow Phenprocoumon: new trials by email Literature Review of Phenprocoumon trials Research Report on Phenprocoumon

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
Apixaban, Phenprocoumon - Atrial Fibrillation, End-stage Kidney Disease
Phase 3CompletedAtrial Fibrillation Network1082017-06-202022-09-27
Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation
Edoxaban, VKA-Based Regimen - Atrial Fibrillation
Phase 3CompletedDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company6322017-03-212019-09-23
Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD
Acetylsalicylic acid, Vitamin K antagonist - Cervical Artery Dissection
Phase 3CompletedStefan Engelter1942013-09-012024-05-21
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
low molecular weight heparin, vitamin K antagonists - Venous Thromboembolism, Neoplasms
Phase 3TerminatedUniversity Medical Center Groningen562010-08-012014-12-03
D-Dimer Guided Oral Anticoagulant Treatment (OAT)
Phenprocoumon, Warfarin-Natrium - Deep Venous Thrombosis
Phase 3UnknownUniversity Hospital, Bonn3002008-02-012009-05-08

Conditions studied

Atrial Fibrillation (2)  ·  Venous Thromboembolism (2)  ·  Venous Thrombosis (2)  ·  Kidney Diseases (1)  ·  Kidney Failure, Chronic (1)  ·  Neoplasms (1)  ·  Thrombophilia (1)

Sponsors

Atrial Fibrillation Network (1)  ·  Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (1)  ·  Stefan Engelter (1)  ·  University Hospital, Bonn (1)  ·  University Medical Center Groningen (1)

Countries

Germany (5)  ·  Canada (2)  ·  Italy (2)  ·  Belgium (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Bernd Poetzsch, Professor (1)  ·  Harry R. Buller, MD, PhD (1)  ·  Holger Reinecke, Prof. Dr. (1)  ·  Pieter W. Kamphuisen, MD, PhD (1)  ·  Stefan T. Engelter, MD (1)

Results publications

PMID 29663464, PMID 30206088, PMID 33249467, PMID 36335915, PMID 39910883

NIH funding

2016 (1)